MLA 0.00% 8.5¢ medical australia limited

Dakfifty comments

  1. SS9
    5 Posts.
    Building on Dakfifty comments -

    I posted a while ago and said that this share price was heading for the gutter after Donnison left. FYI the problem with MLA since Donnison left is as follows IMO:

    - the vendors (founders) of Medivet took their shares and walked ( CEO Shaneel Khan and founder Garry Andrews are no longer there).
    - that is why MLA divested the "equine performance" business (see Q3 report) - no one there to run it
    - only hope for MLA to grow quickly was in the hands of Jeremy Delk, CEO of Medivet America and director of MLA now.

    If MLA divest sections of the business now it could be very good or very bad for us shareholders. Like Dakfifty - good news or bad news?

    I suggest that Hancox looks up Donnison and brings him back to finish what he started, because not much has occurred since he left - other than an sp slide from $0.42 to $0.07. And yes Dak, STI for CEO to keep sp above $0.12 for eight weeks is laughable!! Not convinced Hancox wants to sell off any of the business as it would be foolish right now IMO. But the silence (apart from the chirping crickets) does suggest a sale or takeover is in the wings.


    And for the record, IMO if there is activity here then that should have been made public to shareholders under the continuous disclosure rules that a public company is bound by.
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.